Semiquantitative Analysis in PET/CT Imaging of Prostate Cancer.
1/5 보강
Prostate cancer is the second most common cancer, affecting millions of men globally and having a significant burden on health care systems.
APA
Fragkiadaki V, Ntanasis-Stathopoulos I, et al. (2025). Semiquantitative Analysis in PET/CT Imaging of Prostate Cancer.. Journal of clinical medicine, 14(11). https://doi.org/10.3390/jcm14113828
MLA
Fragkiadaki V, et al.. "Semiquantitative Analysis in PET/CT Imaging of Prostate Cancer.." Journal of clinical medicine, vol. 14, no. 11, 2025.
PMID
40507593 ↗
Abstract 한글 요약
Prostate cancer is the second most common cancer, affecting millions of men globally and having a significant burden on health care systems. During recent years, the rapid development of the nuclear medicine field and the wide use and application of positron emission tomography combined with computed tomography (PET/CT) have significantly changed the diagnosis, treatment approach and patient outcomes. Semiquantitative analysis in PET/CT imaging quantifies the load of the disease in patients diagnosed with prostate cancer without measuring the precise amount of a radiotracer injected into the patient; instead, there is an indirect evaluation of the radiotracer using semiquantitative indices. Beginning with the standard uptake value (SUV) in Fluorodeoxyglucose (FDG) PET/CT, various semiquantitative measures have been created and are now used for analyzing different radiotracers. The purpose of this review is to provide an overview of the importance of the semiquantitative analysis in PET/CT imaging with the use of prostate-specific radiotracers at the initial staging of prostate cancer, as well as in biochemical recurrence and in the metastatic state.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Prostate Cancer Care for Men with an Intellectual Disability: A Population-based Cohort Study of Symptoms, Diagnosis, Treatment, and Survival.
- Association between polygenic risk scores and cardiovascular events in prostate cancer patients receiving androgen deprivation therapy in Han Chinese.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Interleukin-11: A pivotal player and potential therapeutic target in prostate cancer.
- Comparative Detection Performance of PSMA and Non-PSMA PET Tracers in Recurrent and Primary Prostate Cancer: A Systematic Review and Network Meta-Analysis.